Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 213

The DOI matches its Crossref record.

α‐Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects

TOELLER, M.·1994·European Journal of Clinical Investigation

Abstract

With α‐glucosidase inhibitors generally improved metabolic control is achieved in NIDDM patients regardless of whether acarbose is administered in addition to other oral anti‐diabetic agents or to diet alone. The most significant finding is the reduction of postprandial blood glucose concentrations. Long‐term studies show a decrease in glycosylated haemoglobin and often also in fasting blood glucose levels. Placebo‐controlled studies have proven that postprandial insulin concentrations are decreased under acarbose treatment while fasting plasma insulin is usually unchanged. The major side‐effects of acarbose treatment involve the gastrointestinal system and include flatulence, abdominal discomfort and diarrhoea. Symptoms diminish with treatment time and are less severe when the treatment is started with low doses. Acarbose should usually be initiated as a 50 mg dose immediately before each major carbohydrate containing meal. Monotherapy with acarbose does not cause hypoglycaemia, however, hypoglycaemia may occur with combination of sulphonylurea or insulin treatment by the well‐known reasons. In this case hypoglycaemia has to be treated by taking glucose.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2362.1994.tb02253.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 213

Metadata

Authors
TOELLER, M.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
1994-08
Volume
24
Issue
S3
Pages
31-35
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W1998869732
Cited by
213
References
0
FWCI
2.23
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: α‐Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects. https://app.cochat.ai/papers/10.1111/j.1365-2362.1994.tb02253.x
The paper
TOELLER, M. (1994). α‐Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.1994.tb02253.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.